Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 18Prostatic Neoplasms 8Osteoporosis 8Vitamin D Deficiency 4Polycystic Ovary Syndrome 4Colonic Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Colorectal Neoplasms 3Bone Diseases, Metabolic 3Obesity 2Neoplasm Metastasis 2Multiple Endocrine Neoplasia Type 1 2Lymphoma 2Lung Neoplasms 2Leukemia 2Inflammation 2Cardiovascular Diseases 2Carcinoma, Transitional Cell 2Brain Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Thyroid Neoplasms 1Solid Cancers 1Sexual Dysfunction, Physiological 1Rectal Neoplasms 1Psoriasis 1Pancreatic Neoplasms 1

Interventions

Oxaliplatin 14Fluorouracil 11Capecitabine 9Surveys and Questionnaires 8Leucovorin 8Irinotecan 8Cisplatin 8Bevacizumab 8Standard of Care 5Gemcitabine 5Drug Therapy 4S 1 (combination) 3Radiotherapy 3Nivolumab 3Interviews as Topic 3IFL protocol 3Educational Status 3Cyclophosphamide 3Colonoscopy 3Blood Specimen Collection 35,10-methylenetetrahydrofolic acid 3trebananib 2tivozanib 2pembrolizumab 2Taxes 2Remote Patient Monitoring 2Pemetrexed 2Panitumumab 2Ocoxin 2N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Gastrointestinal Neoplasms × Vitamin D × Clear all
NCT00585637 2015-04-01

Vitamin D for Chemoprevention

Dana-Farber Cancer Institute

Phase 1 Completed
328 enrolled 11 charts
GastrointestinalGenitourinary

Gastrointestinal Neoplasms, Hypertension, Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡